mRNA vaccines: the most recent clinical applications of synthetic mRNA

Immunology and Microbiology

• DNA Vector 50%
• Immunogenicity 50%
• Large Scale Production 50%
• Plasmid 50%
• Protein Expression 50%
• Severe Acute Respiratory Syndrome Coronavirus 2 50%
• Synthetic Vaccine 50%
• Viral Vector 100%